Genflow Biosciences plc (LON:GENF)
London · Delayed Price · Currency is GBP · Price in GBX 2.140
+0.190 (9.74%)
Aug 14, 2026, 4:35 PM GMT
Genflow Biosciences Market Cap
Genflow Biosciences has a market cap or net worth of 12.12 million as of August 14, 2026. Its market cap has increased by 302.49% in one year.
Market Cap
12.12M
Enterprise Value
12.01M
Revenue
585.61K
Ranking
n/a
PE Ratio
n/a
Stock Price
2.14
ChartMarket Cap Chart
Since January 17, 2022, Genflow Biosciences's market cap has decreased from 33.64M to 12.12M, a decrease of -63.97%. That is a compound annual growth rate of -20.00%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 14, 2026 | 12.12M | 32.75% |
| Dec 31, 2025 | 9.13M | 51.36% |
| Dec 31, 2024 | 6.03M | 44.72% |
| Dec 29, 2023 | 4.17M | -40.63% |
| Dec 30, 2022 | 7.02M | -79.13% |
| Jan 17, 2022 | 33.64M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Arecor Therapeutics | 22.47M |
| IXICO | 16.35M |
| Aptamer Group | 13.82M |
| Fusion Antibodies | 13.14M |
| Palatin Technologies | 12.87M |
| Solvonis Therapeutics | 10.21M |
| Cizzle Biotechnology Holdings | 7.01M |
| OptiBiotix Health | 5.94M |